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Background
Cancer cells display oncogene-driven rewiring of metabo-
lism to produce energy and macromolecules for growth.
Inhibition of growth-promoting metabolic pathways may
prove to be a useful therapeutic strategy in cancer. We
previously identified distinct metabolic platforms that
enabled cancer cells to produce macromolecular precur-
sors from glucose and glutamine, the two most abundant
nutrients. However, neither the full breadth of cancer cell
metabolic diversity, nor the complement of mechanisms
by which tumor mutations elicit metabolic reprogram-
ming, are known. Because metabolic flux can be analyzed
in vitro without any a priori knowledge of tumor genetics
or drug sensitivity, metabolic phenotyping could produce
actionable biomarkers to optimize therapy. Here we used
a well-characterized panel of lung cancer cell lines to
develop the most comprehensive view of cancer cell meta-
bolism to date.
Methods
81 non-small cell lung cancer cell lines were analyzed for a
set of well-defined metabolic parameters. These cell lines
were also subjected to extensive genomic, epigenetic, and
gene expression analysis, and tested for sensitivity to che-
motherapeutic agents and genome-wide siRNA screens.
These rich data sets will streamline the establishment of
novel correlations between metabolism and molecular/cell
biological features. All cell lines were characterized for
nutrient utilization, nutrient addiction, and focused flux
assays to trace the metabolism of isotope-labeled glucose
and glutamine in identical culture condition. Ongoing
experiments are assessing metabolism of the same cells
grown in vivo.
Results
The 81 cell lines displayed surprising metabolic heteroge-
neity. Although all cells used glucose and glutamine to
produce biosynthetic precursors, contributions of these
two nutrients varied considerably, as did the pathways
used. For individual isotopic labeling patterns, differences
of >30-fold were observed across the panel. Unsupervised
clustering produced two metabolic superfamilies differ-
entiated by relatively glucose carbon contribution into
precursor pools, as well as numerous subfamilies which
may correlate to different metabolic pathways. Although
KRAS-mutant cells were distributed across panel, the
LKB1/KRAS co-mutation cells aggregated into the low-
glucose m0 superfamily. Ongoing work will examine the
ability of metabolic phenotyping to predict combinatorial
mutations and vulnerabilities to drugs and siRNAs.
Conclusion
Focused metabolic assays can produce a highly informa-
tive view of the metabolic phenotyping among large
panels of cell lines. It describes an unparalleled view of
the connections between genetics, drug sensitivity and
cell-autonomous metabolism in NSCLC.
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